NF2 and neurofibromatosis: Similar to cytogenetic analysis, these studies identified NF2 mutations as the predominant alteration in both spontaneous (~60%) and Neurofibromatosis syndrome associated (~40%) of tumors (16), at a frequency of 43% in low grade, and nearly 80% in high grade tumors (11).